A Mixed-Method Study for Implementation of Central Line-Associated Bloodstream Infection Control in Intensive Care Units
Implementation of Central Line-Associated Bloodstream Infection Control in Intensive Care Unit Settings: A Mixed-Method Study
This is a phased mixed-method implementation study aiming to develop and evaluate a multi-component central-line-associated bloodstream infection (CLABSI) prevention bundle in three intensive-care units (Respiratory Intensive Care Unit, RICU; Surgical Intensive Care Unit, SICU; Neonatal Intensive Care Unit, NICU) at Peking University First Hospital. This study will first conduct pilot testing of the refined bundle in NICU, then scale-up implementation across all three ICUs. CLABSI incidence rate per 1000 central line-days is the primary outcome; bundle adherence rate and multi-dimensional implementation outcomes are secondary outcomes.
研究概览
地位
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Shuo Li, M.D.
- 电话号码:+86-13671275323
- 邮箱:shuoli_bjmu@126.com
研究联系人备份
- 姓名:Xi Yao, MMSc
- 电话号码:+86-13811429675
- 邮箱:yaoxi@pku.edu.cn
学习地点
-
-
Beijing Municipality
-
Beijing、Beijing Municipality、中国、100034
- 招聘中
- Peking University First Hospital
-
接触:
- Shuo Li, M.D.
- 电话号码:+86-13671275323
- 邮箱:shuoli_bjmu@126.com
-
接触:
- Xi Yao, MMSc
- 电话号码:+86-13811429675
- 邮箱:yaoxi@pku.edu.cn
-
首席研究员:
- Liuyi Li, MMSc
-
首席研究员:
- Hongling Chu, Ph.D.
-
首席研究员:
- Xi Yao, MMSc
-
副研究员:
- Meihua Hu, MMSc
-
副研究员:
- Yuan Cheng, M.D.
-
副研究员:
- Tian Sang, M.D.
-
副研究员:
- Cui Yuan, MMSc
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Admitted to RICU, SICU or NICU of Peking University First Hospital during study period
- Has an indwelling central venous catheter (CVC, non-tunneled), peripherally inserted central catheter (PICC), or umbilical venous catheter (UVC)
- Generates central-line-days within study observation window
Exclusion Criteria:
- CVC placed in external hospitals and not managed within the three participating ICUs
- Central-line-days generated outside study observation period
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:CLABSI Prevention Bundle Intervention Arm
Single-group intervention, implementing multi-component CLABSI prevention bundle in NICU, RICU and SICU with phased roll-out |
A multi-component CLABSI prevention bundle with six core measures: (1) preferable insertion site selection, (2) hand hygiene, (3) maximum sterile barrier precautions, (4) catheter hub disinfection and insertion site care, (5) timely removal of non-essential catheters, and (6) implementation of a standardized checklist. The study adopts a phased implementation design: a pilot phase will first be conducted in NICU to test the bundle, identify implementation barriers, and refine local strategies; after optimization, the refined bundle will be rolled out across RICU, SICU and NICU. Local implementation teams will develop tailored action plans, monitor adherence, and iteratively optimize implementation strategies throughout the study. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
CLABSI incidence rate
大体时间:Baseline through intervention period, up to 36 months
|
CLABSI cases per 1000 central-line-days, defined according to Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) criteria. Calculated as number of CLABSI events divided by total central-line-days multiplied by 1000, collected prospectively in RICU, SICU and NICU. |
Baseline through intervention period, up to 36 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Overall CLABSI prevention bundle adherence score
大体时间:Baseline through implementation period, up to 36 months
|
A composite adherence score calculated as the mean proportion of correctly performed elements across six core CLABSI-prevention bundle measures (hand hygiene, maximum sterile barrier precautions, preferable insertion site, disinfection and site care, nonessential catheter removal, and checklist completion), assessed by direct observation and chart review. The score is expressed as a single percentage ranging from 0% to 100%. |
Baseline through implementation period, up to 36 months
|
|
Acceptability of the CLABSI prevention intervention bundle
大体时间:Entire study duration, up to 36 months
|
Acceptability will be assessed through semi-structured interviews with healthcare professionals involved in implementation to explore perceptions of whether the intervention bundle is agreeable and satisfactory in routine clinical practice. Findings will be reported as qualitative themes and categories. |
Entire study duration, up to 36 months
|
|
Fidelity of implementation of the intervention bundle - Quantitative assessment
大体时间:Entire study duration, up to 36 months
|
The degree to which the intervention bundle is implemented as intended according to predefined implementation procedures, assessed by quantitative process indicators, case audits, and checklists. Fidelity will be reported as the proportion of predefined procedures correctly completed. |
Entire study duration, up to 36 months
|
|
Fidelity of implementation of the intervention bundle - Qualitative assessment
大体时间:Entire study duration, up to 36 months
|
The degree to which the intervention bundle is implemented as intended, assessed through semi-structured interviews with implementation stakeholders. Qualitative findings regarding barriers and facilitators to implementation fidelity will be reported as themes. |
Entire study duration, up to 36 months
|
|
Feasibility of implementation of the intervention bundle
大体时间:Entire study duration, up to 36 months
|
Feasibility will be assessed through semi-structured interviews with healthcare professionals to determine the extent to which the intervention bundle can be successfully implemented within participating intensive care units. Findings will be reported as qualitative themes describing barriers and facilitators to implementation. |
Entire study duration, up to 36 months
|
|
Sustainability of implementation of the intervention bundle - Quantitative assessment
大体时间:Entire study duration, up to 36 months
|
The extent to which implementation of the intervention bundle is maintained over time, assessed using quantitative process indicators. Sustainability will be reported as the proportion of bundle elements continued in routine clinical practice. |
Entire study duration, up to 36 months
|
|
Sustainability of implementation of the intervention bundle - Qualitative assessment
大体时间:Entire study duration, up to 36 months
|
The extent to which implementation of the intervention bundle is integrated into routine clinical practice over time, assessed through semi-structured interviews. Qualitative findings will be reported as themes. |
Entire study duration, up to 36 months
|
合作者和调查者
调查人员
- 首席研究员:Shuo Li, M.D.、Peking University First Hospital
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2024-197-002
- 23-515 (其他赠款/资助编号:China Medical Board)
- 2024研197-002 (其他标识符:Peking University First Hospital Ethics Committee)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Individual-participant data will not be shared publicly because of patient privacy restrictions and local institutional data security requirements. Aggregated study results may be published in peer-reviewed journals.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.